Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Kintor Pharma Announces First Patient Dosing in Multi-Regional Global Phase II Clinical Trial of ALK-1 Antibody and Nivolumab Combination Therapy for the Treatment of Advanced Hepatocellular Carcinoma 2022-05-04 20:36
United Imaging Flips the Script on its Events Program for 2022, Reveals Expanded Sales Force and U.S. Growth 2022-05-03 23:22
China Natural Resources Receives Nasdaq Notification Regarding Minimum Bid Requirements 2022-05-03 04:05
WATERDROP ANNOUNCES APPOINTMENT OF NEW INDEPENDENT DIRECTOR 2022-05-02 20:00
Inmagene Receives FDA's IND Clearance for OX40 Antagonist 2022-05-01 06:00
Concord Medical Files 2021 Annual Report on Form 20-F 2022-04-30 07:15
IONOVA Announces Clinical Trial Collaboration with MSD to Evaluate INV-1120 in Combination with KEYTRUDA® (pembrolizumab) in Patients with Advanced Solid Tumors 2022-04-29 20:00
Waterdrop Files Annual Report on Form 20-F for Fiscal Year 2021 2022-04-29 07:44
Zepp Health Corporation Files 2021 Annual Report on Form 20-F 2022-04-29 05:35
I-Mab Announces Appointments of Richard Yeh as Chief Operating Officer and John Hayslip as Chief Medical Officer 2022-04-29 04:01
Gracell Biotechnologies Announces Details of Oral Abstract Presentation at 2022 ASCO Annual Meeting 2022-04-28 22:30
ReviR Therapeutics Announces Dr. David Dornan as Independent Board Director 2022-04-28 22:00
Lunit to Present 11 Abstracts at the 2022 ASCO Annual Meeting 2022-04-28 21:33
Formosa Pharmaceuticals and AimMax Therapeutics to Present Phase 2 Trials Results of APP13007 for the Treatment after Cataract Surgery at ARVO 2022 Annual Meeting 2022-04-28 20:00
HanAll Biopharma Reports First Quarter 2022 Results and Provides Business Update 2022-04-28 19:00
WuXi Biologics' 2021 ESG Report Reveals Company's Strong Commitment to Overall Sustainability 2022-04-28 08:30
ASCO 2022 | Ascentage Pharma to Present Data from Seven Clinical Studies at the 2022 American Society of Clinical Oncology Annual Meeting 2022-04-28 08:18
AIG Announces Widespread Growth in Q1 2022 2022-04-27 22:25
China Jo-Jo Drugstores Regains Compliance with Nasdaq Minimum Bid Price Requirement 2022-04-27 20:30
Alterity Therapeutics Announces Regulatory Authorization to Proceed with ATH434 Phase 2 Clinical Trial in the United Kingdom 2022-04-27 19:40
1 150 151 152 153 154 801